Mucopolysaccharidoses (MPS) are a group of rare lysosomal storage diseases (LSD) with multi-organic and severe symptoms. MPS occur worldwide in various forms though have relative a low incidence. The prevalent type of MPS varies among different continents, indicating that it may be associated with region and ethnic background. Undegraded glycosaminoglycans (GAGs) induced by deficiency of enzymes are the primary cause of MPS. Clinical features differ depending on the specific enzyme deficiency including coarse facial features, cognitive retardation, hepatosplenomegaly, hernias, kyphoscoliosis, corneal clouding, etc. Symptoms of different types are usually similar especially MPS I and II, but may have distinguishable features such as severe neurological problems in MPS III and hydrops fetails in MPS VII. These clinical features contribute to diagnosis, but early and precisely diagnosis in the asymptomatic stage is imperative for better outcomes. Novel approaches including urinary and blood GAG test, enzyme assay and gene test help to diagnose MPS and to determine its subtype. Hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT) are conventional treatment for MPS, but are not effective at treating all MPS. Newer threatments, such as advanced ERT, gene therapy and substrate reduction therapy (SRT), improve therpeutic efficacy. In this review, we update information on the clinical manifestations, diagnosis, and treatment of the different forms of this disease in the hopes of stimulating further interest in MPS.
"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410002184882698241","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000408477659"}],"foaf:name":[{"@language":"en","@value":"Zhou Jing"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China."},{"@language":"en","@value":"The Academy of Integrative Medicine of Fudan University, Shanghai, China."},{"@language":"en","@value":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases, Shanghai, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410002184882698243","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000408477661"}],"foaf:name":[{"@language":"en","@value":"Leung Wing Ting"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China."},{"@language":"en","@value":"The Academy of Integrative Medicine of Fudan University, Shanghai, China."},{"@language":"en","@value":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases, Shanghai, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410002184882698240","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000408477660"}],"foaf:name":[{"@language":"en","@value":"Lin Jing"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China."},{"@language":"en","@value":"The Academy of Integrative Medicine of Fudan University, Shanghai, China."},{"@language":"en","@value":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases, Shanghai, China."}]},{"@id":"https://cir.nii.ac.jp/crid/1410002184882698242","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000408477662"}],"foaf:name":[{"@language":"en","@value":"Wang Ling"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China."},{"@language":"en","@value":"The Academy of Integrative Medicine of Fudan University, Shanghai, China."},{"@language":"en","@value":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases, Shanghai, China."}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"2186361X"},{"@type":"PISSN","@value":"21863644"}],"prism:publicationName":[{"@language":"en","@value":"Intractable & Rare Diseases Research"},{"@language":"ja","@value":"Intractable & Rare Diseases Research"},{"@language":"en","@value":"IRDR"}],"dc:publisher":[{"@language":"en","@value":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement"},{"@language":"ja","@value":"特定非営利活動法人 バイオ＆ソーシャル・サイエンス推進国際研究交流会"}],"prism:publicationDate":"2020-02-29","prism:volume":"9","prism:number":"1","prism:startingPage":"1","prism:endingPage":"9"},"reviewed":"false","url":[{"@id":"https://www.jstage.jst.go.jp/article/irdr/9/1/9_2020.01011/_pdf"}],"availableAt":"2020-02-29","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=mucopolysaccharidosis","dc:title":"mucopolysaccharidosis"},{"@id":"https://cir.nii.ac.jp/all?q=symptom","dc:title":"symptom"},{"@id":"https://cir.nii.ac.jp/all?q=diagnosis","dc:title":"diagnosis"},{"@id":"https://cir.nii.ac.jp/all?q=treatment","dc:title":"treatment"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011144265828608","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"First Report of a Patient with MPS Type VII, Due to Novel Mutations in GUSB, Who Underwent Enzyme Replacement and Then Hematopoietic Stem Cell Transplantation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144315803520","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Preclinical Studies of Lymphocyte Gene Therapy for Mild Hunter Syndrome (Mucopolysaccharidosis Type II)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145045863552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145135915392","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145977711104","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146584086656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Live-Birth Prevalence of Mucopolysaccharidoses in Estonia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292618700519040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094108459008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Characterization of pulmonary function impairments in patients with mucopolysaccharidoses—changes with age and treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095343273216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mucopolysaccharidosis VI"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095416428544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095463830144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical and Biochemical Manifestations of Hyaluronidase Deficiency"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095667596800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569339773568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mucopolysaccharidosis IVA and glycosaminoglycans"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569632233728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Incidence of the mucopolysaccharidoses in Taiwan, 1984–2004"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571069703296","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571462086400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Recent advances in molecular testing to improve early diagnosis in children with mucopolysaccharidoses"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043665612800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044215473792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044254256512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Diagnosis of Mucopolysaccharidosis Based on History and Clinical Features: Evidence from the Bajio Region of Mexico"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045005937408","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Neurophysiology of hearing in patients with mucopolysaccharidosis type IV"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045453011840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mucopolysaccharidosis type